About GLP FAQ

About GLP FAQ: a peer community where people on GLP-1 medications share experiences, side-effect tips, and weight-loss progress. Not medical advice.

GLP FAQ launched in 2026 as an independent online community for people using or considering GLP-1 receptor agonist medications (semaglutide, tirzepatide, and related drugs sold under names including Ozempic, Wegovy, Mounjaro, Zepbound, and Saxenda).

The site combines a peer-discussion forum with an editorial reference library. Discussions are written and moderated by our community; reference articles are produced by our editorial team and reviewed against published clinical sources.

We are based in the United States and operate independently of any pharmaceutical manufacturer, telehealth platform, or compounding pharmacy. We do not employ medical practitioners — for any medical question, please consult your own licensed healthcare provider.

Contact

For comments, corrections, or business inquiries: [email protected]

Contact us via email for all correspondence.

Back
Top